B

Baiden, F, Fleck, S, Leigh, B, Ayieko, P, Tindanbil, D, Otieno, T, Lawal, B, Tehtor, M, Rogers, M, Odeny, L, Hodges, MH, Sonnie, M, Samai, M, Ishola, D, Lowe, B, Watson-jones, D and Greenwood, B (2022). Prevalence of malaria and helminth infections in rural communities in northern Sierra Leone, a baseline study to inform Ebola vaccine study protocols. S1 Data. [Data Collection]. PLOS ONE. https://doi.org/10.1371/journal.pone.0270968.s001

G

Gombe, B, Streatfield, C, Leal, L, Opio, S, Joseph, S, Weber, J, Hare, J, Kaleebu, P and Serwanga, J (2022). Optimization and validation of an ELISA assay for the determination of antibody responses to CN54gp140 and AIDSVAX BE for use in the Phase IIb PrEPVacc vaccine trial. S1 Data. [Data Collection]. PLOS ONE. https://doi.org/10.1371/journal.pone.0275927.s001

N

Nyiro, JU, Sande, CJ, Mutunga, M, Kiyuka, PK, Munywoki, PK, Scott, JAG and Nokes, DJ (2016). Absence of Association between Cord Specific Antibody Levels and Severe Respiratory Syncytial Virus (RSV) Disease in Early Infants: A Case Control Study from Coastal Kenya. [Data Collection]. PLOS One. https://doi.org/10.1371/journal.pone.0166706

P

Procter, SR (2023). mert0248/GBS-vax-econ-model. [Data Collection]. Github. https://github.com/mert0248/GBS-vax-econ-model